Liquiritin, as a Natural Inhibitor of AKR1C1, Could Interfere With the Progesterone Metabolism.

Zeng, Chenming; Zhu, Difeng; You, Jun; Dong, Xiaowu; Yang, Bo; Zhu, Hong; He, Qiaojun

Zeng, Chenming; Zhu, Difeng; You, Jun; Dong, Xiaowu; Yang, Bo; Zhu, Hong; He, Qiaojun.

Afiliación

Zeng C; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Zhu D; College of Pharmaceutical Sciences, Center for Drug Safety Evaluation and Research of Zhejiang University, Zhejiang University, Hangzhou, China.
You J; Zhejiang Cancer Hospital, Hangzhou, China.
Dong X; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Yang B; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Zhu H; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
He Q; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.

Front Physiol ; 10: 833, 2019.

Article en En | MEDLINE | ID: mdl-31333491

Palabras clave

AKR1C1; inhibitor; liquiritin; pre-term birth prevention; progesterone metabolism

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Physiol Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google